GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » GlucoTrack Inc (NAS:GCTK) » Definitions » Shiller PE Ratio

GlucoTrack (GlucoTrack) Shiller PE Ratio : (As of Jun. 02, 2024)


View and export this data going back to 2000. Start your Free Trial

What is GlucoTrack Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


GlucoTrack Shiller PE Ratio Historical Data

The historical data trend for GlucoTrack's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlucoTrack Shiller PE Ratio Chart

GlucoTrack Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

GlucoTrack Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of GlucoTrack's Shiller PE Ratio

For the Medical Instruments & Supplies subindustry, GlucoTrack's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlucoTrack's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, GlucoTrack's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where GlucoTrack's Shiller PE Ratio falls into.



GlucoTrack Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

GlucoTrack's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, GlucoTrack's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.6/131.7762*131.7762
=-0.600

Current CPI (Mar. 2024) = 131.7762.

GlucoTrack Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 50.700 100.560 66.439
201409 -10.400 100.428 -13.646
201412 -9.750 99.070 -12.969
201503 -20.150 99.621 -26.654
201506 -21.450 100.684 -28.074
201509 -14.300 100.392 -18.771
201512 -19.500 99.792 -25.750
201603 -15.600 100.470 -20.461
201606 -19.500 101.688 -25.270
201609 -19.500 101.861 -25.227
201612 -15.600 101.863 -20.181
201703 -31.200 102.862 -39.970
201706 -31.200 103.349 -39.782
201709 -28.600 104.136 -36.191
201712 -30.550 104.011 -38.705
201803 -22.100 105.290 -27.659
201806 -21.450 106.317 -26.587
201809 -20.150 106.507 -24.931
201812 -245.700 105.998 -305.453
201903 -0.650 107.251 -0.799
201906 -0.650 108.070 -0.793
201909 -0.650 108.329 -0.791
201912 -0.650 108.420 -0.790
202003 -0.262 108.902 -0.317
202006 -0.200 108.767 -0.242
202009 -0.150 109.815 -0.180
202012 -0.350 109.897 -0.420
202103 -0.300 111.754 -0.354
202106 -0.300 114.631 -0.345
202109 -0.250 115.734 -0.285
202112 -0.450 117.630 -0.504
202203 -0.350 121.301 -0.380
202206 -0.350 125.017 -0.369
202209 -0.300 125.227 -0.316
202212 -0.450 125.222 -0.474
202303 -0.400 127.348 -0.414
202306 -0.450 128.729 -0.461
202309 -0.500 129.860 -0.507
202312 -0.500 129.419 -0.509
202403 -0.600 131.776 -0.600

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


GlucoTrack  (NAS:GCTK) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


GlucoTrack Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of GlucoTrack's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GlucoTrack (GlucoTrack) Business Description

Traded in Other Exchanges
N/A
Address
301 Route 17 North, Suite 800, Rutherford, New Jersey, NJ, USA, 07070
GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It also focuses on developing a wireless module for transmission of measurement data captured by the GlucoTrack model DF-F to a cloud-based server.
Executives
James S Cardwell officer: Chief Financial Officer CLINTON SQUARE, 75 S. CLINTON AVE., SUITE 510, ROCHESTER NY 14604
Erin Catherine Carter director 301 RTE 17 NORTH, STE. 800, RUTHERFORD NJ 07070
Allen Danzig director 301 RT 17 NORTH, SUITE 800, RUTHERFORD NJ 07070
Shimon D Rapps director C/O ANDREW GARRETT, INC., 52 VANDERBILT AVENUE SUITE 510, NEW YORK NY 10017
Drew Sycoff director C/O ANDREW GARRETT INC, 52 VANDERBILT AVENUE - 20TH FLOOR, NEW YORK NY 10017
David Podwalski officer: Chief Commercial Officer 19 HA'YAHALOMIM ST., P.O. BOX 12163, ASHDOD L3 7760049
Michael Hauck director 19 HA'YAHALOMIM ST., P.O. BOX 12163, C/O INTEGRITY APPLICATIONS, INC., ASHDOD L3 7760049
John A Graham director, officer: Chief Executive Officer 19 HA'YAHALOMIM STREET, P.O. BOX 12163, ASHDOD L3 7760049
Sami Sassoun officer: Chief Financial Officer 39-06 ACKERMAN DRIVE, FAIR LAWN L3 7760049
Philip Darivoff director 1 FARMSTEAD ROAD, SHORT HILLS NJ 07078
Revan Schwartz director 19 HA'YAHALOMIM ST., P.O. BOX 12163, C/O INTEGRITY APPLICATIONS, INC., ASHDOD L3 7760049
Angela Strand Boydston director C/O AEROGEN, INC., 2071 STIERLIN COURT, MOUNTAIN VIEW CA 94043
Leslie Seff director PO BOX 59, 40 HELLBROOK LANE, ULSTER PARK NY 12487
Eran Hertz officer: Chief Financial Officer C/O INTEGRITY APPLICATIONS, INC., 102 HA'AVODA STREET, P.O. BOX 432, ASHKELON L3 L3 78100
Israel B. Ehrlich director C/O INTEGRITY APPLICATIONS, INC., 102 HA'AVODA STREET, P.O. BOX 432, ASHKELON L3 L378100